Literature DB >> 427788

Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.

J C Allegra, M E Lippman, E B Thompson, R Simon, A Barlock, L Green, K K Huff, H M Do, S C Aitken.   

Abstract

The distribution and frequency of steroid hormone receptors are described 329 patients with breast cancer. The distribution of each of the steroid hormone receptors is unimodal with a progressive increase in the proportion of patients positive at lower receptor values. Receptor values expressed as fmol/mg cytoplasmic protein are well correlated with values expressed as fmol/mg breast tumor. Estrogen receptor was positive in 53% of the patients; progesterone receptor was positive in 38% of the patients; glucocorticoid receptor was positive in 52% of the patients; and androgen receptor was positive in 31% of the patients. The type of tissue assayed did not affect steroid hormone receptor positivity. For primary tumors, there was no correlation between steroid hormone receptor positivity and location of the tumor in the breast, size of the tumor, or extent of the disease. Each of the steroid hormone receptors was positively associated with each of the other steroid hormone receptors. Estrogen receptor was correlated with menopausal status and axillary nodal status, but these correlations did not exist for the other steroid hormone receptors. Estrogen receptor was not correlated with age after adjustment for menopausal status. The other steroid hormone receptors were not correlated with age.

Entities:  

Keywords:  Adrenal Cortex Hormones; Androgens; Biology; Breast Cancer; Cancer; Correlation Studies; Diseases; Endocrine System; Estrogens; Histology; Hormone Receptors--analysis; Hormones; Laboratory Procedures; Membrane Proteins; Neoplasms; Physiology; Progestational Hormones; Progesterone; Research Methodology; Statistical Studies; Studies

Mesh:

Substances:

Year:  1979        PMID: 427788

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  37 in total

1.  Effects of glucocorticoids on the growth and chemosensitivity of carcinoma cells are heterogeneous and require high concentration of functional glucocorticoid receptors.

Authors:  Yen-Shen Lu; Huang-Chun Lien; Pei-Yen Yeh; Kun-Huei Yeh; Min-Liang Kuo; Sung-Hsin Kuo; Ann-Lii Cheng
Journal:  World J Gastroenterol       Date:  2005-10-28       Impact factor: 5.742

Review 2.  Structural and Functional Biology of Aldo-Keto Reductase Steroid-Transforming Enzymes.

Authors:  Trevor M Penning; Phumvadee Wangtrakuldee; Richard J Auchus
Journal:  Endocr Rev       Date:  2019-04-01       Impact factor: 19.871

3.  A model of gene-environment interaction reveals altered mammary gland gene expression and increased tumor growth following social isolation.

Authors:  J Bradley Williams; Diana Pang; Bertha Delgado; Masha Kocherginsky; Maria Tretiakova; Thomas Krausz; Deng Pan; Jane He; Martha K McClintock; Suzanne D Conzen
Journal:  Cancer Prev Res (Phila)       Date:  2009-09-29

4.  Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line.

Authors:  R Poulin; D Baker; F Labrie
Journal:  Breast Cancer Res Treat       Date:  1988-10       Impact factor: 4.872

5.  Relationship between the content of estrogen and progesterone receptors and the pathological characteristics in human breast cancer.

Authors:  R Nishimura; A Misumi; M Kimura; T Tokunaga; M Akagi
Journal:  Jpn J Surg       Date:  1982

6.  Animal models for hormone-dependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate.

Authors:  P M Martin; M Cotard; J P Mialot; F André; J P Raynaud
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333

Review 7.  Endocrine therapy for advanced breast cancer: a review.

Authors:  H B Muss
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

8.  Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast.

Authors:  K S McCarty; J S Silva; E B Cox; G S Leight; S A Wells; K S McCarty
Journal:  Ann Surg       Date:  1983-02       Impact factor: 12.969

9.  Fluoxymesterone stimulation of tumor marker secretion in patients with breast carcinoma.

Authors:  W G Dilley; D E Haagensen; G S Leight; S Ammirata; S R Davis; J S Silva; N Zamcheck; J J Lokich; S A Wells
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

Review 10.  Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

Authors:  T E Hickey; J L L Robinson; J S Carroll; W D Tilley
Journal:  Mol Endocrinol       Date:  2012-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.